| Literature DB >> 35347391 |
Andreas Selberherr1,2, Marta Mari1,3, Markus Klinger1, Christopher Burghuber1, Wolf Eilenberg1, Bernd Gollackner1, Christoph Neumayer1, Christoph Domenig4.
Abstract
BACKGROUND: In this study, we evaluate the outcome of renal function in patients undergoing juxtarenal abdominal aortic aneurysm repair with or without division of the left renal vein with special focus on the role of the communicating lumbar vein.Entities:
Mesh:
Year: 2022 PMID: 35347391 PMCID: PMC9054893 DOI: 10.1007/s00268-022-06480-6
Source DB: PubMed Journal: World J Surg ISSN: 0364-2313 Impact factor: 3.282
Demographic characteristics of patients (group A vs. group B)
| Characteristics | Total cohort ( | Suprarenal clamp + LRV division patients (group A; | Suprarenal clamp + LRV mobilization patients (group B; | |
|---|---|---|---|---|
| Sex, male, | 90 (81.8%) | 65 (80.2%) | 25 (86.2%) | 0.475 |
| Age, years, mean ± SD | 69.5 ± 8.7 | 68.8 ± 9.3 | 71.4 ± 6.6 | 0.179 |
| ASA, median | 3.04 | 3.04 | 3.03 | 0.985 |
| Dialysis, | 1 (0.9%) | 1 (1.2%) | 0 | 0.552 |
| CKD stage ≥ 3b, | 14 (12.7%) | 9 (11.1%) | 5 (17.5%) | 0.525 |
| Dyslipidemia, | 69 (62.7%) | 48 (59.3%) | 21 (72.4%) | 0.212 |
| Diabetes mellitus, | 17 (15.5%) | 14 (17.3%) | 3 (10.3%) | 0.380 |
| Hypertension, | 94 (85.5%) | 68 (84.0%) | 26 (89.7%) | 0.459 |
| Smoker, | 66 (60.0%) | 53 (65.4%) | 13 (44.8%) | 0.053 |
| CAD, | 46 (41.8%) | 30 (37.0%) | 16 (55.2%) | 0.091 |
| Peripheral artery disease, | 36 (32.7%) | 29 (35.8%) | 7 (24.1%) | 0.255 |
| Pulmonary disease, | 34 (30.9%) | 23 (28.4%) | 11 (37.9%) | 0.345 |
CKD chronic kidney disease; CAD coronary artery disease
Demographic characteristics of patients (group A+ vs. group A−)
| Characteristics | Total cohort ( | Suprarenal clamp + LRV division patients + communicating lumbar vein present (group A+ ; | Suprarenal clamp + LRV division patients + communicating lumbar vein missing (group A−; | |
|---|---|---|---|---|
| Sex, male, | 65 (80.2%) | 17 (68.0%) | 45 (80.4%) | 0.225 |
| Age, years, mean ± SD | 68.8 ± 9.3 | 68.9 ± 7.7 | 68.8 ± 10.0 | 0.959 |
| ASA, median | 3.04 | 2.84 | 3.13 | 0.064 |
| Dialysis, | 1 (1.2%) | 0 | 1 (1.8%) | 0.507 |
| CDK stage ≥ 3b, | 9 (11.1%) | 2 (8.0%) | 7 (12.5%) | 0.114 |
| Dyslipidemia, | 48 (59.3%) | 16 (64.0%) | 32 (57.1%) | 0.567 |
| Diabetes mellitus, | 14 (17.3%) | 3 (12.0%) | 11 (19.6%) | 0.407 |
| Hypertension, | 68 (84.0%) | 21 (84.0%) | 47 (84.0%) | 0.994 |
| Smoker, | 53 (65.4%) | 15 (60.0%) | 38 (67.9%) | 0.498 |
| CAD, | 30 (37.0%) | 9 (36.0%) | 21 (37.5%) | 0.899 |
| Peripheral artery disease, | 29 (35.8%) | 8 (32.0%) | 21 (37.5%) | 0.638 |
| Pulmonary disease, | 23 (28.4%) | 5 (20.0%) | 18 (32.1%) | 0.269 |
CKD chronic kidney disease; CAD coronary artery disease
Serum creatinine (sCr) and eGFR values (group A vs. group B)
| Characteristics | Total cohort ( | Suprarenal clamp + LRV division patients (group A; | Suprarenal clamp + LRV mobilization patients (group | |
|---|---|---|---|---|
| sCr (mg/dl) | 1.2 | 1.17 | 1.27 | 0.271 |
| eGFR (ml/min/1.73m2) | 73.32 | 72.31 | 61.18 | 0.699 |
| sCr (mg/dl) | 1.46 | 1.57 | 1.17 | 0.086 |
| sCr (mg/dl) | 1.48 | 1.59 | 1.18 | 0.119 |
| sCr (mg/dl) | 1.38 | 1.46 | 1.16 | 0.126 |
| eGFR (ml/min/1.73m2) | 67.39 | 66.91 | 68.73 | 0.726 |
| sCr (mg/dl) | 1.2 | 1.16 | 1.24 | 0.646 |
| eGFR (ml/min/1.73m2) | 70.61 | 72.35 | 65.2 | 0.303 |
| sCr (mg/dl) | 1.29 | 1.31 | 1.17 | 0.619 |
| eGFR (ml/min/1.73m2) | 73.92 | 74.01 | 73.50 | 0.975 |
Serum Creatinine (sCr) and eGFR values (group A+ vs. group A−)
| Characteristics | Total cohort ( | Suprarenal clamp + LRV division patients + communicating lumbar vein present (group A+ ; | Suprarenal clamp + LRV division patients + communicating lumbar vein missing (group A−; | |
|---|---|---|---|---|
| sCr (mg/dl) | 1.17 | 1.12 | 1.19 | 0.471 |
| eGFR (ml/min/1.73m2) | 72.31 | 79.64 | 69.04 | 0.063 |
| sCr (mg/dl) | 1.57 | 1.36 | 1.66 | 0.295 |
| sCr (mg/dl) | 1.59 | 1.46 | 1.64 | 0.591 |
| sCr (mg/dl) | 1.46 | 1.37 | 1.49 | 0.605 |
| eGFR (ml/min/1.73m2) | 66.91 | 72.18 | 64.56 | 0.209 |
| sCr (mg/dl) | 1.16 | 1.01 | 1.23 | 0.262 |
| eGFR (ml/min/1.73m2) | 72.35 | 76.13 | 70.71 | 0.487 |
| sCr (mg/dl) | 1.31 | 0.87 | 1.51 | 0.016 sig. |
| eGFR (ml/min/1.73m2) | 74.01 | 96.23 | 64.29 | 0.041 sig. |
Fig. 1Example of a patient with a strong communicating lumbar vein pre- (a) and 5 years post-operatively (b)